Literature DB >> 24383848

Activated prothrombin complex concentrate for dabigatran-associated bleeding.

Sam Schulman1, Bruce Ritchie, Jennifer K Goy, Susan Nahirniak, Mohammad Almutawa, Shari Ghanny.   

Abstract

Entities:  

Keywords:  bleeding activated prothrombin complex concentrate; dabigatran

Mesh：

Substances：

Year:  2013        PMID： 24383848     DOI： 10.1111/bjh.12620

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  14 in total

Review 1.  Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation and Associated Intracranial Hemorrhage: A Focused Review.

Authors:  Boris Arbit; Jonathan C Hsu
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

Review 2.  The impact of prothrombin complex concentrates when treating DOAC-associated bleeding: a review.

Authors:  Maureane Hoffman; Joshua N Goldstein; Jerrold H Levy
Journal:  Int J Emerg Med       Date:  2018-12-03

Review 3.  Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Authors:  Kamrouz Ghadimi; Jerrold H Levy; Ian J Welsby
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

Review 4.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

5.  Management of new oral anticoagulants related life threatening or major bleedings in real life: a brief report.

Authors:  Luca Masotti; Gianni Lorenzini; Cristiana Seravalle; Grazia Panigada; Giancarlo Landini; Roberto Cappelli; Sam Schulman
Journal:  J Thromb Thrombolysis       Date:  2015-05       Impact factor: 2.300

Review 6.  Prevention and Treatment of Bleeding with Direct Oral Anticoagulants.

Authors:  R Monroe Crawley; Rachel L Anderson
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

7.  The Role of FEIBA in Reversing Novel Oral Anticoagulants in Intracerebral Hemorrhage.

Authors:  Jamil R Dibu; Jonathan M Weimer; Christine Ahrens; Edward Manno; Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

Review 8.  Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates.

Authors:  Lisa M Baumann Kreuziger; Joseph C Keenan; Colleen T Morton; David J Dries
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

Review 9.  A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents.

Authors:  Stephanie A Joppa; Justin Salciccioli; Jill Adamski; Salma Patel; Waldemar Wysokinski; Robert McBane; Farah Al-Saffar; Heidi Esser; Fadi Shamoun
Journal:  J Clin Med       Date:  2018-02-11       Impact factor: 4.241

Review 10.  Efficacy of prothrombin complex concentrates for the emergency reversal of dabigatran-induced anticoagulation.

Authors:  Oliver Grottke; James Aisenberg; Richard Bernstein; Patrick Goldstein; Menno V Huisman; Dara G Jamieson; Jerrold H Levy; Charles V Pollack; Alex C Spyropoulos; Thorsten Steiner; Gregory J Del Zoppo; John Eikelboom
Journal:  Crit Care       Date:  2016-04-28       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.